Govt Job: For M.Pharm under Ministry of Health and Family Welfare

HLL Lifecare Limited (HLL) is a Govt. of India healthcare products manufacturing and services company based in Thiruvananthapuram, Kerala, India under the Union Ministry of Health and Family Welfare, HLL is a global leader in the area of contraceptives, hospital products, and healthcare services.

With 8 manufacturing units, 4 subsidiary / joint venture companies, and 21 regional offices. HLL exports products to over 85 countries.

Besides this, HLL is engaged in providing healthcare and diagnostic services, consultancy and contract services for healthcare infrastructure projects, and consultancy services for the procurement of medical equipment and devices in the healthcare sector.

Thus, HLL is positioned as a total healthcare solution provider catering to the well-being of society at large.

Post: Junior Technical Associate (Natural Products – Pharma)

Qualification :
Essential: Master’s degree in M.Pharm (Pharmaceutics) with 60% marks

Post Qualification Experience
Essential: Minimum two years of research experience in phytochemical extraction, preparation of different types of formulations, and formulation studies.

Experience in In vitro/in vivo assays
Desirable: Experience in animal experiments

The basic pay range (for fixed-term contract engagement) is Rs. 10,000–20,000/- (The basic pay will be fixed within the pay range based on the candidate’s qualification, experience, and current pay).

However, in addition to Basic Pay, DA, HRA, and Perks will be applicable in fixing the final salary)

Location : Trivandrum

Maximum Age: 30 years as on 01.10.2022

Job Profile
1. Development of different types of herbal formulation and formulation studies

2. Animal-based preclinical study of formulations

General Conditions
• Applications that are not in the prescribed format will not be considered for the selection process, and no additional communication will be sent.

• Application Format can be downloaded from the website.

• Job title and Reference code should be clearly mentioned in the Application form

• SC/ST/OBC/PwD candidates will be eligible for relaxation as per Government of India directives.

• Canvassing in any form will be a disqualification.

Candidates can send the following details to recruiter@lifecarehll.com
Attachments:

• Duly filled Application

• Updated CV

• Copies of All Education certificates (10th, 12th, Graduation, PG, Diploma)

• Copies of All Experience & Relieving certificates, Latest  Salary Slip

• Community Certificate/ Disability Certificate

Last Date: 02.11.2022

Reference Code: HLL/HR/044/2022

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert